The Iraqi Hypertension Society with the collaboration of Boehringer Ingelheim pharmaceutical company held a scientific symposium at Oyoon Baghdad Restaurant on this Friday, 19 of July 2024 entitled ” Cardio-Renal Metabolic Forum” in which it discussed the spectrum of cardiorenal metabolic continuum in diabetes and the role of SGLT-2 Inhibitors in improving the outcome in such patients and their significant beneficial role in reducing the cardiovascular complications and in also reducing the progression of chronic renal disease.
Three eminent speakers covered this subject, Dr. Qassim Mudalal, an Interventional Cardiologist at Baghdad Cardiac Center, Dr. Ali allawi, a Consultant Nephrologist at medical City, and Dr Salim Alibrahimi a Consultant Endocrinologist from Alnajaf Medical Center.
the meeting was moderated by Prof Ghazi Haji,
At the end of the session there was a panel discussion to answer the questions of the audience. The meeting was attended by a lot of senior doctors in addition to a number of college students who were welcomed warmly by Dr Ghazi for their will to participate in these activities.